Corporate News
Bridgebio Pharma (BBIO) – Market Performance Snapshot
Last Trading Day
Bridgebio Pharma closed 0.28 % higher during a 24‑hour period ending at 05:07 AM Central Europe on Saturday, 24 th.
The closing price was USD 68.56 on major exchanges.
Shares Outstanding and Market Capitalisation
Shares outstanding: 195.5 million.
Market capitalisation: USD 13.2 billion.
Trading Volume
Total value of shares traded in the last 24 hours: USD 203.8 million.
Recent Performance
Since the end of the previous month, the stock has decreased by 2.15 %.
200‑day simple moving average: USD 72.96.
Historical Extremes
52‑week high: USD 93.42 (recorded on 07/09/2026).
52‑week low: USD 56.74 (recorded on 10/27/2025).
Related Stock Movements (Last 24 Hours)
| Ticker | Company | % Change | Current Price (USD) | Market Cap (USD bn) | P/E Ratio |
|---|---|---|---|---|---|
| BURL | Burlington Stores | +1.81 % | 247.63 | 15.6 | 22.3 |
| CRBG | Corebridge | +0.82 % | 34.13 | 15.7 | 20.58 |
| RBA | Rb Global | +2.91 % | 84.19 | 15.7 | 35.2 |
| TYL | Tyler | +4.44 % | 390.14 | 15.4 | 49.81 |
| PFGC | Performance Food | +0.98 % | 94.71 | 15.3 | 42.42 |
Company Profile – Bridgebio Pharma
Bridgebio Pharma, Inc. is a biotechnology company focused on developing treatments for genetic diseases. The company is headquartered in Palo Alto, United States, and operates globally. Bridgebio Pharma is listed on the Nasdaq stock exchange and can be accessed for further information at www.bridgebio.com .